These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19105207)

  • 1. Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down-modulation.
    Ney JT; Schmidt T; Kurts C; Zhou Q; Eckert D; Felsher DW; Schorle H; Knolle P; Tüting T; Barchet W; Büttner R; Limmer A; Gütgemann I
    Hepatology; 2009 Feb; 49(2):471-81. PubMed ID: 19105207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo modulation of antigen-experienced cells in response to high-dose oral antigen: deletion but no evidence for alterations in the cytokine phenotype.
    Blumenthal-Barby F; Eulenburg K; Schrage A; Zeitz M; Hamann A; Klugewitz K
    Int Immunol; 2008 Jul; 20(7):893-900. PubMed ID: 18492659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin inflammation is not sufficient to break tolerance induced against a novel antigen.
    Holcmann M; Stoitzner P; Drobits B; Luehrs P; Stingl G; Romani N; Maurer D; Sibilia M
    J Immunol; 2009 Jul; 183(2):1133-43. PubMed ID: 19570825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy.
    Bai XF; Liu JQ; Joshi PS; Wang L; Yin L; Labanowska J; Heerema N; Zheng P; Liu Y
    Cancer Res; 2006 Aug; 66(16):8241-9. PubMed ID: 16912204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-primed splenic CD8+ T cells impede the development of oral antigen-induced allergic diarrhea.
    Yamada A; Ohshima Y; Yasutomi M; Ogura K; Tokuriki S; Naiki H; Mayumi M
    J Allergy Clin Immunol; 2009 Apr; 123(4):889-94. PubMed ID: 19201014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma.
    Boudousquié C; Pellaton C; Barbier N; Spertini F
    Clin Exp Allergy; 2009 Sep; 39(9):1415-26. PubMed ID: 19624523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinoma.
    Stahl S; Sacher T; Bechtold A; Protzer U; Ganss R; Hämmerling GJ; Arnold B; Garbi N
    Immunol Lett; 2009 Mar; 123(1):31-7. PubMed ID: 19428549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG priming of dendritic cells enhances T regulatory and Th1 function and suppresses allergen-induced Th2 function in vitro and in vivo.
    Ahrens B; Gruber C; Rha RD; Freund T; Quarcoo D; Awagyan A; Hutloff A; Dittrich AM; Wahn U; Hamelmann E
    Int Arch Allergy Immunol; 2009; 150(3):210-20. PubMed ID: 19494518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.
    Saint-Lu N; Tourdot S; Razafindratsita A; Mascarell L; Berjont N; Chabre H; Louise A; Van Overtvelt L; Moingeon P
    Allergy; 2009 Jul; 64(7):1003-13. PubMed ID: 19220212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
    Conforti A; Peruzzi D; Giannetti P; Biondo A; Ciliberto G; La Monica N; Aurisicchio L
    J Immunother; 2009 Sep; 32(7):744-54. PubMed ID: 19561534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired antibody responses but normal proliferation of specific CD4+ T cells in mice lacking complement receptors 1 and 2.
    Carlsson F; Getahun A; Rutemark C; Heyman B
    Scand J Immunol; 2009 Aug; 70(2):77-84. PubMed ID: 19630912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
    Itsumi M; Yoshikai Y; Yamada H
    Eur J Immunol; 2009 Jul; 39(7):1784-93. PubMed ID: 19544306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
    Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
    Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
    J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth.
    Kim EY; Teh SJ; Yang J; Chow MT; Teh HS
    J Immunol; 2009 Nov; 183(10):6051-7. PubMed ID: 19841176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor.
    Elinav E; Adam N; Waks T; Eshhar Z
    Gastroenterology; 2009 May; 136(5):1721-31. PubMed ID: 19208357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted liposomal delivery of TLR9 ligands activates spontaneous antitumor immunity in an autochthonous cancer model.
    Hamzah J; Altin JG; Herringson T; Parish CR; Hämmerling GJ; O'Donoghue H; Ganss R
    J Immunol; 2009 Jul; 183(2):1091-8. PubMed ID: 19561111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.